In this study, we show that lysosomal cysteine protease cathepsin L regulated GCase stability and suggest that chemical inhibition of cathepsin L activity represents a potential therapeutic strategy for GBA1-associated PD and related diseases. The gene discussed is GBA1; the disease is Parkinson disease.